63281 Real-World Comorbidities of Adult Patients With Prurigo Nodularis Initiating Dupilumab in the US
Nicholas Mollanazar(University of Pennsylvania Health System), Kwinten Bosman(Regeneron (United States)), Raj Chovatiya(Rosalind Franklin University of Medicine and Science), Joseph Zahn(Regeneron (United States)), Tiange Yu, Vipul Jain(McMaster University), Simmi Wiggins(Sanofi (United Kingdom)), Danielle L. Isaman(Aetion (United States)), Daniel Butler(Torbay and South Devon NHS Foundation Trust), Natalia Petruski‐Ivleva(AVEO Oncology (United States))
Cited by 1
Related Papers
JAK inhibitors in the treatment of atopic dermatitis
|Journal of Allergy and Clinical Immunology|2021|361
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
|Annals of the Rheumatic Diseases|2023|95
Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study
|American Journal of Epidemiology|2020|66